Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin for Brain Radiation Damage
NCT00492089Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2007
- Primary completion
- Aug 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in radiation necrosis (RN), sponsored by National Cancer Institute. Started Jun 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
radiation necrosis (RN)
Beyond the preview
Go deeper on NCT00492089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00492089.